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on a damaged template may be key elements of radiosensitization by FdUrd (Lawrence et al., 1996) .
Ionizing radiation produces many types of DNA damage, and it is thought that the ineffective repair of DNA double strand breaks (dsbs) contributes most strongly to cytotoxicity (Ward, 1990) . Until recently the most commonly proposed models for radiosensitization by antimetabolites included either an increase in DNA dsbs prior to or with radiation compared to radiation alone, or the inhibition of the repair of DNA dsbs after irradiation. While FdUrd has been demonstrated to enhance cytotoxicity when administered with radiation by inhibiting the repair of radiation-induced DNA damage, radiosensitization can also occur in the absence of detectable DNA dsbs, thus suggesting another mechanism exists to explain the radiosensitizing effect of these drugs (Bruso et al., 1990; Davis et al., 1995) . Our recent studies with another antimetabolite radiosensitizer, gemcitabine (dFdCyd), demonstrated that, at radiosensitizing concentrations, the dFdCyd-mediated depletion in dATP pools via inhibition of ribonucleotide reductase (RR) produced DNA mismatches that, if left unrepaired, resulted in radiosensitization (Flanagan et al., 2007) . These studies also demonstrated a role for the mismatch repair (MMR) protein MLH1 whereby cells deficient in MLH1 were unable to repair drug induced DNA mismatches and were more easily radiosensitized than MLH1-expressing, presumably MMRproficient cells.
The FdUMP-mediated inhibition of TS and subsequent depletion in dTTP results in the inhibition of DNA synthesis (Martomo and Mathews, 2002; Meyers et al., 2003) , and induces perturbations in the levels of the other deoxynucleotides (dATP, dGTP, and dCTP) through feedback mechanisms (Longley et al., 2003) . dNTP imbalances (in particular dATP/dTTP ratio) are thought to severely disrupt DNA synthesis and repair (Houghton et al., 1995) and can MOL #43349 6 produce errors in DNA replication such as single base substitutions, and insertions or deletions, resulting in frameshift mutagenesis and a damaged template (Bebenek et al., 1992; Martomo and Mathews, 2002) . The depletion of dTTP pools in the presence of FdUrd may contribute to the decreased ability to perform DNA repair (Lawrence et al., 1993) . The MMR system plays a role in correcting DNA mismatches during replication (Kunkel and Erie, 2005) and has been demonstrated to play a role in cytotoxicity of FdUrd whereby MMR-deficient cells are significantly more resistant to the drug than their MMR-proficient counterparts (Carethers et al., 1999; Meyers et al., 2001; Meyers et al., 2005) . However, a role for MMR in the radiosensitizing property of FdUrd has not been explored.
We hypothesize that MMR deficiency will enhance radiosensitization by FdUrd by preventing correction of misincorporated nucleotides in DNA produced by depleted dTTP. We have evaluated this hypothesis in two colorectal carcinoma cell lines, HCT116 and SW620 cells, that differ in their expression of MLH1, a required MMR protein. While we postulate that dTTP depletion leads to nucleotide misincorporation in DNA, it has not been demonstrated that FdUrd can produce these lesions. The present study directly tests the hypothesis that the dNTP pool imbalances produced by FdUrd can produce mismatches in DNA, and that these are the lesions that result in radiosensitization.
Materials and Methods
Cell Culture, Plasmid, and Drug Preparation. HCT116 colon carcinoma cells are MMRdeficient due to inactivation of MLH1. The HCT116 1-2 cell line was produced from the parental HCT116 colon carcinoma cell line and contains wild-type MLH1 cDNA while the HCT116 0-1 cell line contains the vector without the MLH1 insert (Jacob et al., 2001) . SW620 This article has not been copyedited and formatted. The final version may differ from this version. colon carcinoma cells are considered MMR-proficient since they express the two major MMR proteins, MLH1 and MSH2 (Taverna et al., 2000) . All cells were maintained in Dulbecco's modified essential medium (DMEM) (Invitrogen), supplemented with 10% fetal calf serum (Invitrogen), and 2 mM L-glutamine (Fisher Scientific). FdUrd (Sigma Chemical Co., St. Louis, MO) was dissolved in PBS. Cell cycle distribution was determined by dual parameter (propidium iodide(PI)/5-bromo-2'-deoxyuridine (BrdUrd)) flow cytometric analysis as described (Ostruszka and Shewach, 2000) , and DNA synthesis was measured by BrdUrd incorporation (Ostruszka and Shewach, 2003) .
Cell Survival and Radiosensitization Assay. Cells were left untreated or treated with FdUrd at various concentrations for 24 h prior to irradiation [Co 60 (AECL Theratron 80) at 1-2 Gy/min].
Following FdUrd and/or IR (0, 2, 5, 7.5, and 10 Gy), cells were assessed for clonogenic survival as described previously (Shewach et al., 1994) . Radiation sensitivity is expressed in terms of the mean inactivation dose (D-bar), which represents the area under the cell survival curve (Fertil et al., 1984) . Radiosensitization is expressed as an enhancement ratio, which is defined as the mean inactivation dose (control)/mean inactivation dose (drug).
Determination of nucleotide pools. Nucleotides were extracted from cells using 0.4 N perchloric acid, neutralized, and ribonucleotides were removed using a boronate affinity column (Shewach et al., 1994) . Cellular dNTPs were separated and quantified using a strong anion exchange column (Whatman, Hillshore, OR) with a high pressure liquid chromatography (HPLC) system (Waters Milford, MA) equipped with a photodiode array detector and controlled by Millennium 2010 software. Nucleotides were eluted at 2 ml/min with a linear gradient of ammonium phosphate buffer (0.15 M, pH 2.8 to 0.60 M, pH 2.9 or 3.4). Nucleotides were This article has not been copyedited and formatted. The final version may differ from this version. (Seidman et al., 1985) . The assay was performed as previously described (Flanagan et al., 2007) . Briefly, cells were transfected with the pSP189 plasmid overnight, incubated with FdUrd for 24 hr and plasmid extracted 24 hr later.
Replicated plasmid DNA was electroporated into MBM7070 E. coli, and transformants were grown on agar plates with ampicillin and X-gal. White and blue colonies were enumerated, and mutation frequencies were calculated as # white colonies / # (white + blue) colonies. DNA from some control and all mutant clones was isolated and sequenced at the University of Michigan DNA Sequencing Core using the 20-mer primer (5'-GGCGACACGGAAATGTTGAA). Proteins were separated by SDS-PAGE on 10% acrylamide gels and transferred onto Immobilon-P transfer membrane (Millipore Corp., Bedford, MA). Membranes were probed with MLH1 polyclonal rabbit IgG antibodies (Santa Cruz Biotechnology) at 1:100 and anti-rabbit IgG horseradish peroxidase linked antibodies at 1:20 000 dilutions. Proteins were detected and visualized using an enhanced chemiluminescence detection system (Pierce, Rockford, IL). irradiating cells after a 24 hr incubation with FdUrd at equitoxic concentrations (IC 10 or IC 50 ).
Results

Cytotoxicity and radiosensitization with
As illustrated in Table 1 , MLH1-inactivated HCT116 cells were radiosensitized at a noncytotoxic concentration, whereby ≥IC 10 FdUrd produced an excellent radiation enhancement ratio (RER = 1.8). In contrast, incubation with <IC 50 of FdUrd did not significantly enhance the sensitivity of the HCT116 MLH1-wildtype cells to radiation-induced cytotoxicity (RER < 1.2), however significant radiosensitization was observed at the IC 90 (RER = 1.4 ± 0.1).
Effect of FdUrd on dNTP Pools and Cell Cycle Distribution.
Since dTTP depletion is necessary for radiosensitization with FdUrd (Davis et al., 1995) , we wished to determine whether the inability of the MLH1 proficient HCT116 1-2 cells to undergo radiosensitization by FdUrd was due to lesser depletion of dTTP compared to the MLH1 inactivated HCT116 0-1 cells.
Equitoxic concentrations (IC 50 ) of FdUrd produced similar changes in dTTP and other dNTPs in each cell line at 4 hr, with ~ 40% reduction in dTTP and > 50% reduction in dGTP with a concomitant >35% increase in dATP (Table 2 ). This pattern of dNTP effects is typical following FP administration (Wadler et al., 1996) . At 24 hr the HCT116 MLH1-inactivated cells displayed an increase in dTTP, dATP and dGTP while all four dNTPs were depressed in the MLH1-wildtype cells.
Previous studies have demonstrated that radiosensitization with FdUrd depends upon the ability of cells to enter S-phase during drug exposure (McGinn et al., 1994; Miller and Kinsella, 1992) . To determine whether MLH1 inactivation altered the cell cycle progression of HCT116 cells treated with FdUrd, cell cycle distribution was measured for 72 hr following the end of drug exposure by dual parameter (BrdU and PI) flow cytometry. Both cell lines exhibited similar Sphase accumulation (>66%) following incubation for 24 h with FdUrd (IC 50 ) (Table 3) 
Effect of FdUrd on Mutation Frequency in HCT116 cell lines.
Since differential effects on dNTP pools or cell cycle distribution could not explain the inability of FdUrd to radiosensitize the MLH1-wildtype HCT116 cells, we evaluated the functional effect of dNTP pool imbalances on producing errors in DNA replication using a plasmid mutation assay. Cells were transfected with pSP189 plasmid, and FdUrd or no drug (control) was added for 24 hr. The mutation frequencies in plasmids replicated in the untreated control group of both cell lines were similar (0.11 % ± 0.025, and 0.12 % ± 0.025, in MLH1-inactivated or MLH1-wildtype cells, respectively; p < 0.05), as reported by others (Jeong et al., 1999; Tobi et al., 1999) . Although
FdUrd (IC 50 ) decreased dTTP by >40% for at least 24 hr in MLH1-expressing HCT116 1-2 cells, there was no significant increase in the plasmid mutation frequency at this drug concentration.
In contrast, in HCT116 0-1 MLH1-inactivated cells, FdUrd (IC 50 ) decreased dTTP by ~40% for <24 hr, yet this concentration resulted in a significantly (nearly 8-fold) increased plasmid mutation frequency compared to control (0.83% + 0.005, and 0.11% + 0.025, respectively; p<0.0001; Fig. 1A ).
Radiosensitization by FdUrd in MMR-proficient cells following shRNA-mediated
suppression of MLH1 expression. After demonstrating that MLH1-inactivation was associated with radiosensitization by FdUrd and an increased plasmid mutation frequency, we used shRNA technology to decrease expression of wildtype MLH1 in the HCT116 1-2 cells and examined the ability of FdUrd to enhance IR sensitivity. In addition, we examined another cell line, SW620, to determine whether the effect of MLH1 on radiosensitization and cytotoxicity by FdUrd was unique to the HCT116 cell lines or could also be reproduced in other cells. Previous studies This article has not been copyedited and formatted. The final version may differ from this version. (Davis et al., 1995) . In our studies, SW620 cells did not exhibit significant radiosensitization until a highly toxic concentration of FdUrd (3.5 µ M, IC 90 ) was used (RER = 1.4 + 0.04), similar to the HCT116 MLH1-wildtype cells (Table 1) . After transduction of SW620 and HCT116 1-2 cells with lentivirus-delivered MLH1 shRNA and selection for transduced cells, nearly complete depletion of MLH1 protein was observed in both cell lines by 5 days and it remained depressed through at least 9 days post-transduction ( Fig. 1B and C) . The ability of FdUrd to radiosensitize SW620 and HCT116 1-2 cells was examined by irradiating cells after a 24 hr incubation with FdUrd. As illustrated in Table 1 
Discussion
It is generally accepted that depletion of dTTP, due to FdUMP-mediated inhibition of TS, is the primary effect that produces radiosensitization with FPs. Although it has been suggested that dTTP depletion may slow the rate of repair of radiation-induced dsbs, that radiosensitization can occur in the absence of detectable DNA dsbs suggests other mechanism(s) exist to explain the This article has not been copyedited and formatted. The final version may differ from this version. radiosensitizing effect of these drugs (Bruso et al., 1990 ). Here we provide evidence that the FdUrd-mediated decrease in dTTP produces mismatches in DNA which, while not required for cytotoxicity, are associated with radiosensitization. This is the first demonstration of a lesion in DNA that leads to radiosensitization with FdUrd. Furthermore, demonstration that MLH1 deficiency induced both mismatches in DNA and radiosensitization suggests that errors of replication play an integral role in radiosensitization with FdUrd.
To evaluate the role of MLH1 in radiosensitization with FdUrd, we initially measured the cytotoxicity of FdUrd + ionizing radiation in the HCT116 0-1 (inactivated MLH1) and HCT116
1-2 (wildtype MLH1) cells. As reported by others, the HCT116 1-2 cells were more sensitive to FdUrd (Meyers et al., 2003; Meyers et al., 2005) ; however, innate sensitivity to ionizing radiation was similar. Therefore, to evaluate both a non-cytotoxic (IC 10 ) and a cytotoxic (IC 50 ) concentration of FdUrd on radiosensitization in the cell lines, we used equitoxic rather than equimolar concentrations of FdUrd. Under these conditions only the MLH1-inactivated HCT116 0-1 cells exhibited radiosensitization. Both cell lines exhibited similar effects on the two parameters required for radiosensitization with FPs, dTTP depletion and accumulation in Sphase. Indeed, dTTP depletion was more prolonged in the HCT116 1-2 cells, yet no radiosensitization was observed at <IC 50 .
To further support our hypothesis that MLH1 plays a role in FdUrd-mediated radiosensitization, we used shRNA technology to return the HCT116 1-2 MLH1-wildtype cells to the MLH1 deficiency status of the parental cell line. Following MLH1 suppression we were able to radiosensitize these cells at a concentration of FdUrd shown here to be unable to increase cytotoxicity by ionizing radiation (Table 1) . Similarly, the suppression of MLH1 expression in the SW620 cell line induced radiosensitization and, as in the HCT116 matched cell lines, This article has not been copyedited and formatted. The final version may differ from this version. FdUrd, a concentration that also significantly increased mismatches.
Compared to the matched HCT116 cell lines, cultured separately over many years, suppression of MLH1 expression with lentivirus-delivered shRNA in the SW620 cells should allow a more accurate determination of the effect of MLH1 on radiosensitization and plasmid mutation frequency with FdUrd. Indeed, the demonstration that MLH1 suppression induced both mismatches and radiosensitization with FdUrd demonstrates a causal role for MLH1 deficiency in these processes.
Both HCT116 1-2 and SW620 cells express high levels of at least one MMR protein (Taverna et al., 2000) and are resistant to radiosensitization at moderate concentrations of FdUrd. have about 2-fold less MLH1 protein and 40-fold less MSH2 than SW620 cells (Taverna et al., 2000) , but are more susceptible to the combination of FdUrd and ionizing radiation (Davis et al., 1995) . In our studies only a toxic concentration of FdUrd (IC 90 ) in SW620 cells and HCT116 1-2 MLH1-wildtype cells produced radiosensitization and an increase in plasmid mutations. We hypothesize that, at low levels of FdUrd, the existing MMR capability is sufficient to correct errors of replication resulting from an imbalance in dNTP pools, but can be overcome at sufficiently high concentrations of FdUrd that induce an increase in misincorporated nucleotides.
Since FdUrd can exert its cytotoxic effects through incorporation into DNA as well as through the inhibition of TS (Mader et al., 1998) , it is difficult to eliminate the contribution of DNA incorporation to radiosensitization. However, since FdUMP incorporation into DNA is associated with cytotoxicity (Ingraham et al., 1982) , the decreased cytotoxicity of FdUrd in
MLH1-deficient cells compared to MLH1-wildtype cells under radiosensitizing conditions
suggests that radiosensitization can not be attributed to an increase in FdUMP incorporation into DNA. Furthermore, previous studies have determined that the radiosensitizing effect of FdUrd is not dependent on cytotoxicity (Davis et al., 1995) . TS inhibition also produces an accumulation of dUMP, which may lead to increased levels of dUTP (Biserka et al., 1994) , and a possible increase in dUTP incorporation into DNA (Ingraham et al., 1982) , thus supplying another possible contributor to radiosensitization. We did not observe appreciable levels of dUTP in the HCT116 cell lines following FdUrd exposure. SW620 cells displayed a small amount of dUTP (data not shown), although the amount was similar regardless of MLH1 status. Therefore, this metabolite does not provide an explanation for the radiosensitization that occurred when MLH1
was suppressed or inactivated.
This article has not been copyedited and formatted. The final version may differ from this version. Following FdUrd exposure, all of the cells used in our studies, regardless of MLH1 status, exhibited S-phase cell cycle arrest, a response strongly correlated with radiosensitization by FdUrd (Lawrence et al., 1996; McGinn et al., 1994; Miller and Kinsella, 1992 ). Some studies have described a shorter G2 arrest after FP treatment in HCT116 MMR-deficient versus their MMR-proficient counterparts, (Meyers et al., 2001 ) whereas others did not (Carethers et al., 1999) , although drug concentration and exposure time varied. We used a moderate and equitoxic concentration of FdUrd for a moderate exposure time and did not observe a difference in G2 response between MMR-proficient and MMR-deficient cells. Thus, differential effects on cell cycle progression cannot explain FdUrd radiosensitization observed in MLH1-inactivated but not MLH1-wildtype cells. Although the HCT116 MLH1-wildtype and MLH1-inactivated cells continued to progress through the cell cycle after FdUrd washout whereas the SW620 cells progressed little (Table 3) , within a cell line progression was similar regardless of MLH1 status.
Furthermore, since a similar rate of DNA synthesis (as determined by the incorporation of BrdUrd, data not shown) was observed after drug washout within each cell line, regardless of MLH1 status, differences in mutation frequency cannot be attributed to DNA synthesis inhibition.
Despite similar effects on cytotoxicity, dNTP pools, and cell cycle distribution, only a radiosensitizing concentration of FdUrd produced an increase in plasmid mutation frequency in two different cell lines. These studies support our previous findings with dFdCyd and hydroxyurea, radiosensitizers that produce an imbalance in dNTP pools (primarily a decrease in dATP) due to inhibition of RR, where mismatches in DNA occurred only under radiosensitizing conditions, and MLH1 deficiency enhanced radiosensitization (Flanagan et al., 2007) . Together these studies strongly support errors of replication as a general mechanism of radiosensitization This article has not been copyedited and formatted. The final version may differ from this version. for drugs that produce imbalances in dNTPs. Importantly, we have demonstrated that a decrease in dTTP produces different replication errors than drugs that produce decreases primarily in dATP (Flanagan et al., 2007) , yet a strong relationship between DNA errors and radiosensitization still exists. These results demonstrate an important role for MLH1 and further implicate insufficient MMR in radiosensitization with drugs that produce dNTP imbalances.
Finally, these data suggest that tumors with innate or acquired deficiency in MLH1 would be most sensitive to radiosensitization with FdUrd, but that higher doses of drug could be used in MLH1-expressing tumors to increase their radiosensitivity. Furthermore, the dependence of radiosensitization on DNA mismatches and not cytotoxicity suggests that, if clinical treatment with FdUrd and IR could be titrated to maximize DNA mismatches in tumors rather than cytotoxicity, normal tissue toxicity may be lessened. An understanding of the lesions and repair pathways leading to radiosensitization will aid us in optimizing chemoradiotherapy with the clinically important fluoropyrimidines.
This article has not been copyedited and formatted. The final version may differ from this version. Exponentially growing HCT116 MLH1-wildtype and MLH1-inactivated cells were incubated with an IC 50 for FdUrd or left untreated (control). SW620 cells were left untreated or transduced with shRNA targeted to MLH1 mRNA or non-specific (NS) shRNA. Four days following shRNA treatment, exponentially growing cells were incubated with IC 50 for FdUrd or left untreated (control). dNTP pools were extracted and analyzed as described in "Materials and Methods". The data are presented as a % of the corresponding control value and represent the mean ± SD from duplicate determinations. Control values (pmol dNTP/10 6 cells): HCT116 0-1 cells, dCTP: 3.43 ± 1.0, dTTP: 29.7 ± 3.0, dATP: 6.1 ± 1.1, dGTP: 2.05 ± 0.6. HCT116 1-2 cells, dCTP: 4.0 ± 1.7, dTTP: 32.9 ± 2.8, dATP: 6.7 ± 0.8, dGTP: 1.97 ± 0.4. SW620, dCTP: 3.67 ± 0.5, dTTP: 20.05 ± 1.3, dATP: 3.55 ± 0.2, dGTP: 0.85 ± 0.04. SW620 +NSshRNA, dCTP: 7.06 ± 0.6, dTTP: 37.6 ± 3.1, dATP: 8.1 ± 0.2, dGTP: 1.84 ± 0.1. SW620 +MLH1shRNA, dCTP: 5.73 ± 1.3, dTTP: 21.42 ± 0.8, dATP: 4.93 ± 0.4, dGTP: 1.54 ± 0.5. This article has not been copyedited and formatted. The final version may differ from this version. Zero hour represents the time at drug washout after a 24-hr incubation with IC 50 FdUrd. Cells were harvested at the time indicated and cell cycle distribution was analyzed by dual flow cytometry as described in "Materials and Methods". 
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